These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7419008)

  • 1. Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease.
    Bishop AE; Polak JM; Bryant MG; Bloom SR; Hamilton S
    Gastroenterology; 1980 Nov; 79(5 Pt 1):853-60. PubMed ID: 7419008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal mucosa diamine oxidase activity reflects intestinal involvement in Crohn's disease.
    Thompson JS; Burnett DA; Markin RS; Vaughan WP
    Am J Gastroenterol; 1988 Jul; 83(7):756-60. PubMed ID: 3132852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microaggregate of immunostained macrophages in noninflamed gastroduodenal mucosa: a new useful histological marker for differentiating Crohn's colitis from ulcerative colitis.
    Yao K; Yao T; Iwashita A; Matsui T; Kamachi S
    Am J Gastroenterol; 2000 Aug; 95(8):1967-73. PubMed ID: 10950044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide-containing nerve fibres in the gut wall in Crohn's disease.
    Sjölund K; Schaffalitzky OB; Muckadell DE; Fahrenkrug J; Håkanson R; Peterson BG; Sundler F
    Gut; 1983 Aug; 24(8):724-33. PubMed ID: 6192043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease.
    Mazumdar S; Das KM
    Am J Gastroenterol; 1992 Feb; 87(2):176-81. PubMed ID: 1370872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered inhibitory innervation of circular smooth muscle in Crohn's colitis. Association with decreased vasoactive intestinal polypeptide levels.
    Koch TR; Carney JA; Go VL; Szurszewski JH
    Gastroenterology; 1990 Jun; 98(6):1437-44. PubMed ID: 2338187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease.
    O'Morain C; Bishop AE; McGregor GP; Levi AJ; Bloom SR; Polak JM; Peters TJ
    Gut; 1984 Jan; 25(1):57-61. PubMed ID: 6360814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peptidergic nerves in the colon of patients with ulcerative colitis.
    Tomita R; Tanjoh K; Fujisaki S; Fukuzawa M
    Hepatogastroenterology; 2000; 47(32):400-4. PubMed ID: 10791200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of vasoactive intestinal polypeptide nerves in esophageal achalasia.
    Aggestrup S; Uddman R; Sundler F; Fahrenkrug J; Håkanson R; Sørensen HR; Hambraeus G
    Gastroenterology; 1983 May; 84(5 Pt 1):924-7. PubMed ID: 6832568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colonic vasoactive intestinal polypeptide (VIP) in ulcerative colitis--a radioimmunoassay and immunohistochemical study.
    Todorovic V; Janic B; Koko V; Micev M; Nikolic JA; Ratkovic M; Leposavic G; Jankovic T; Knezevic-Usaj S; Milicevic Z
    Hepatogastroenterology; 1996; 43(9):483-8. PubMed ID: 8799381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
    Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular changes in ulcerative colitis and Leśniowski-Crohn's disease.
    Zurawski J; Woźniak A; Salwa-Zurawska W; Kaczmarek E; Majewski P
    Pol J Pathol; 2007; 58(1):13-21. PubMed ID: 17585538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
    Griga T; Voigt E; Gretzer B; Brasch F; May B
    Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
    Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
    Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
    Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
    Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time PCR quantification analysis of five mucosal transcripts in patients with Crohn's disease.
    Eriksson A; Jennische E; Flach CF; Jorge A; Lange S
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):290-6. PubMed ID: 18334872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of vasoactive intestinal peptide receptor 1 expression in inflammatory bowel disease.
    Yukawa T; Oshitani N; Yamagami H; Watanabe K; Higuchi K; Arakawa T
    Int J Mol Med; 2007 Aug; 20(2):161-7. PubMed ID: 17611633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colon mucosa of patients both with spondyloarthritis and Crohn's disease is enriched with macrophages expressing the scavenger receptor CD163.
    Demetter P; De Vos M; Van Huysse JA; Baeten D; Ferdinande L; Peeters H; Mielants H; Veys EM; De Keyser F; Cuvelier CA
    Ann Rheum Dis; 2005 Feb; 64(2):321-4. PubMed ID: 15166002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axonal degeneration/necrosis: a possible ultrastructural marker for Crohn's disease.
    Steinhoff MM; Kodner IJ; DeSchryver-Kecskemeti K
    Mod Pathol; 1988 May; 1(3):182-7. PubMed ID: 3237698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.